The human Fc receptor for IgA (FcαRI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis

Immunology Letters

Volumn 68, Issue 1, 1999, Pages 83-87

  Van Egmond, Marjolein ^a   Hanneke Van Vuuren, A J ^a,b   Van De Winkel, Jan G J ^a,b  

^a Department of Immunology   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CD89; Fc RI; Macrophage; Transgenic

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN A;

ANIMAL CELL; CANCER INHIBITION; CONFERENCE PAPER; CYTOLYSIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN STRUCTURE; IMMUNOREGULATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; CELLS, CULTURED; CROSSES, GENETIC; CYTOTOXICITY, IMMUNOLOGIC; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN A; MACROPHAGES, PERITONEAL; MICE; MICE, CONGENIC; MICE, TRANSGENIC; PHAGOCYTOSIS; RECEPTORS, FC; TUMOR CELLS, CULTURED;

EID: 0344327050     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(99)00034-6     Document Type: Conference Paper

References (21)

1. Kerr M.A. Biochem. J. 271:1990;285-296.
2. Morton H.C., van Egmond M., van de Winkel J.G.J. Crit. Rev. Immunol. 16:1996;423-440.
3. Monteiro R.C., Kubagawa H., Cooper M.D. J. Exp. Med. 171:1990;597-613.
4. Maliszewski C.R., March C.G., Schoenborn M.A., Gimpel S., Shen L. J. Exp. Med. 172:1990;1665-1672.
5. de Wit T.P.M., Morton H.C., Capel P.J.A., van de Winkel J.G.J. J. Immunol. 155:1995;1203-1209.
6. Morton H.C., Schiel A.E., Janssen S.W.J., van de Winkel J.G.J. Immunogenetics. 43:1996;246-247.
7. Valerius T., Stockmeyer B., van Spriel A.B. et al. Blood. 90:1997;4485-4492.
8. Deo Y.M., Sundarapandiyan K., Keler T., Wallace P.K., Graziano R.F. J. Immunol. 160:1998;1677-1686.
9. Pfefferkorn L.C., Yeaman G.R. J. Immunol. 153:1994;3228-3236.
10. Morton H.C., van den Herik-Oudijk I.E., Vossebeld P., Snijders A., Verhoeven A.J., Capel P.J.A., van de Winkel J.G.J. J. Biol. Chem. 270:1995;29781-29787.
11. Reterink T.J., van Zandbergen G., van Egmond M, Klar-Mohamad N., Morton H.C., van de Winkel J.G.J., Daha M.R. Eur. J. Immunol. 27:1997;2219-2224.
12. Shen L., Collins J.E., Schoenborn M.A., Maliszewski C.R. J. Immunol. 152:1994;4080-4086.
13. Sibille Y., Depelchin S., Staquet P., Chatelain B., Coulie P., Shen L., Vander Maelen C., Vaerman J.P. Eur. Respir. J. 7:1994;1111-1119.
14. M. van Egmond, A.J. van Vuuren, H.C. Morton, A.B. van Spriel, L. Shen, F.M.A. Hofhuis, T. Saito, T.N. Mayadas, J.S. Verbeek, J.G.J van de Winkel, Human IgA receptor (FcαRI, CD89) function in transgenic mice requires both FcR γ-chain and CR3 (CD11b/CD18), Blood (1999) in press.
15. M.W. Fanger, Bispecific Antibodies. R.G. Landes Company Austin, TX, 1995.
16. M.J. Van Vugt, I.A.F.M. Heijnen, P.J.A. Capel, S.Y. Park, C. Ra, T. Saito, J.S. Verbeek, J.G.J van de Winkel, Blood 87 (1996) 3593-3599.
17. I.A.F.M. Heijnen, PhD Thesis. Utrecht University, The Netherlands, 1997.
18. Ely P., Wallace P.K., Givan A.L., Graziano R.F., Guyre P.M., Fanger M.W. Blood. 87:1996;3813-3821.
19. Patry C., Sibille Y., Lehuen A., Monteiro R.C. J. Immunol. 156:1996;4442-4448.
20. Gordon S. Bioessays. 17:1995;977-986.
21. Stewart W.W., Kerr M.A. Immunology. 71:1990;328-334.